Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene

Nature Genetics

Volumn 4, Issue 3, 1993, Pages 233-238

  Sabouri, Luc A ^a   Mahadevan, Mani S ^a   Narang, Monica ^a   Lee, David S C ^c   Surh, Linda C ^b   Korneluk, Robert G ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLYADENYLATED RNA; PROTEIN SERINE THREONINE KINASE; TRINUCLEOTIDE;

ALLELE; ARTICLE; CASE REPORT; CELL LINE; CONTROLLED STUDY; DNA DETERMINATION; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOTONIC DYSTROPHY; NEWBORN; POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTHERN BLOTTING;

ALLELES; BASE SEQUENCE; DNA; GENE AMPLIFICATION; GENE EXPRESSION; GENES, DOMINANT; HUMAN; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; MUTATION; MYOTONIC DYSTROPHY; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN-SERINE-THREONINE KINASES; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0027163546     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0793-233     Document Type: Article

References (48)

1. Vanier, T.M. Dystrophia Myotonia in Childhood. Br. Med. J. 2, 1285-1288 (1960).
2. Harper, P.S., in Myotonic Dystrophy 2nd edn (Saunders, Philadelphia, 1989).
3. Sarnat, H.B. & Silbert, S.W., Maturational Arrest of Fetal Muscle in Neonatal Myotonic Dystrophy. Arch. Neurol. 33, 466-474 (1976).
4. Soussi-Yanicostas, N. et al. Distinct contractile protein profile in congenital myotonic dystrophy and X-linked myotubular myopathy.Neuromusc Dis 1, 103-111 (1992).
5. Aslanidis, C. et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355, 548-551 (1992).
6. Mahadevan, M. et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255, 1253-1255 (1992).
7. Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTQ) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68, 799-808 (1992).
8. Buxton, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547-548 (1992).
9. Fu, Y.H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256-1258 (1992).
10. Jansen, G. et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nature Genet. 1, 261-266 (1992).
11. Harley, H.G. et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545-546 (1992).
12. Tsilfidis, C., MacKenzie, A.E., Mettler, G., Barcelo, J. & Korneluk, R.G. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nature Genet. 1, 192-195 (1992).
13. Barcelo, J.M., Mahadevan, M.S., Tsilfidis, C., MacKenzie, A.E. & Korneluk, R.G. Intergenerational stability of the myotonic dystrophy protomutation.Hum. molec. Genet. (in the press)
14. Caskey, C.T., Pizzuti, A., Fu, Y.-H., Fenwick, R.G. & Nelson, D.L. Triplet repeat mutations in human disease. Science 256, 784-788 (1992).
15. Richards, R.I. & Sutherland, G.R. Dynamic mutations: A new class of mutations causing human disease. Cell 70, 709-712 (1992).
16. Howeler, C.J., Busch, H.F.M., Geraedts, J.P.M., Niermeijer, M.F. & Staal, A. Anticipation in myotonic dystrophy: fact or fiction? Brain 112, 779-797 (1989).
17. Fu, Y.-H. et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67, 1047-1058 (1991).
18. Annemieke, J.M. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914 (1991).
19. Pieretti, M. et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66, 817-822 (1991).
20. Bell, M.V. et al. Physical mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome. Cell 64, 861-866 (1991).
21. Sutcliffe, J.S. et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. molec. Genet. 1, 397-400 (1992).
22. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79 (1991).
23. The Huntington's disease collaborative research group. Cell 72, 971-983 (1993).
24. McAllister, R.M., Melnyk, J., Finkelstein, J.Z., Adams, E.C.Jr., & Gardner, M.B. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 24, 520-526 (1969).
25. Gililand, G., Perrin, S., Blanchard, K. & Bunn, H.F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. natn. Acad. Sci. U.S.A. 87, 2725-2729 (1990).
26. Fu, Y.-H. et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science260, 235-238 (1993).
27. Zucker, M. & Stiegler, P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucl. Acids Res. 9, 133-148 (1981).
28. Mullner, E.W. & Kuhn, L.C. A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53, 815-825 (1988).
29. Mullner, E.W., Neupert, B. & Kuhn, L.C. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell 58, 373-382 (1989).
30. Peltz, S.W., Brewer, G., Bernstein, P., Hart, P.A. & Ross, J. Regulation of mRNA turnover in eukaryotic cells. Crit. Rev. Euk. Gene Exp. 1, 99-126 (1991).
31. Bernstein, P.L., Herrick, D.J., Prokipcak, R.D. & Ross, J. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding stability determinant. Genes Dev. 6, 642-654 (1992).
32. Dix, D.J., Lin, P.-N., Kimata, Y. & Theil, E.C. The iron regulatory region of ferritin mRNA is also a positive control elememt for iron-independent translation. Biochemistry 31, 2818-2822 (1992).
33. Kaspar, R.L., Kakegawa, T., Cranston, H. & White, M.W. A regulatory cis element and a specific binding factor involved in the mitogenic control of murine ribosomal protein L32 translation. J. biol. Chem. 267, 508-514 (1992).
34. Sengupta, D.N., Berkhout, B., Gatignol, A., Zhou, A. & Silverman, R.H. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. natn. Acad. Sci. U.S.A. 87, 7492-7496 (1990).
35. McCormack, S.J., Thomis, D.C. & Samuel, C.E. Mechanism of interferon action: Identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/elF-2 alpha protein kinase.Virology 188, 47-56 (1992).
36. Wisdom, R. & Lee, W. Translation of c-myc mRNA is required for its post-transcriptional regulation during myogenesis. J. biol. Chem. 265, 19015-19021 (1990).
37. Taylor, S.S., Buechler, J.A. & Yonemoto, W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. An. Rev. Biochem. 59, 971-1005 (1990).
38. Farkas-Bargeton, E. et al. Immaturity of muscle fibers in the congenital form of myotonic dystrophy. J. neurol. Sci. 83, 145-159 (1988).
39. Li, L., Heller-Harrison, R., Czech, M. & Olson, E. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins.Molec. cell. Biol. 12, 4478-4485 (1992).
40. Li, L. et al. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domain. Cell 71, 1181-1194 (1992).
41. Piechaczyk, M. et al. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucl. Acids Res. 12, 6951-6963 (1984).
42. Puissant, C. & Houdebine, L.-M. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biotechniques 8, 148-149 (1990).
43. Birnboim, H.C. Rapid extraction of high molecular weight RNA from cultured cells and granulocytes for Northern analysis. Nucl. Acids Res. 16, 1487-1497 (1988).
44. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual 2nd edn (Cold Spring Harbor, New York 1989).
45. 1arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes. J. cell. Physiol.145, 564-574 (1990).
46. Dretzen, G., Bellard, M., Sassone-Corsi, P. & Chambon, P. A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Anal. Biochem. 112, 295-298 (1981).
47. Feinberg, A.P. & Vogelstein, B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem.132, 6-13 (1983).
48. Mahadevan, M. et al. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum. molec. Genet. (in the press)